143 related articles for article (PubMed ID: 11689268)
1. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B.
Lavasanifar A; Samuel J; Kwon GS
J Control Release; 2001 Nov; 77(1-2):155-60. PubMed ID: 11689268
[TBL] [Abstract][Full Text] [Related]
2. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide).
Lavasanifar A; Samuel J; Kwon GS
J Control Release; 2002 Feb; 79(1-3):165-72. PubMed ID: 11853928
[TBL] [Abstract][Full Text] [Related]
3. Block copolymer micelles for the encapsulation and delivery of amphotericin B.
Lavasanifar A; Samuel J; Sattari S; Kwon GS
Pharm Res; 2002 Apr; 19(4):418-22. PubMed ID: 12033373
[TBL] [Abstract][Full Text] [Related]
4. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.
Adams ML; Kwon GS
J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020
[TBL] [Abstract][Full Text] [Related]
5. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
Yu BG; Okano T; Kataoka K; Kwon G
J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.
Diezi TA; Takemoto JK; Davies NM; Kwon GS
J Pharm Sci; 2011 Jun; 100(6):2064-70. PubMed ID: 21491436
[TBL] [Abstract][Full Text] [Related]
7. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
Adams ML; Andes DR; Kwon GS
Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
10. Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery.
Lavasanifar A; Samuel J; Kwon GS
J Biomed Mater Res; 2000 Dec; 52(4):831-5. PubMed ID: 11033567
[TBL] [Abstract][Full Text] [Related]
11. Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.
Diezi TA; Bae Y; Kwon GS
Mol Pharm; 2010 Aug; 7(4):1355-60. PubMed ID: 20575526
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles.
Elhasi S; Astaneh R; Lavasanifar A
Eur J Pharm Biopharm; 2007 Mar; 65(3):406-13. PubMed ID: 17291732
[TBL] [Abstract][Full Text] [Related]
14. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles.
Vandermeulen G; Rouxhet L; Arien A; Brewster ME; Préat V
Int J Pharm; 2006 Feb; 309(1-2):234-40. PubMed ID: 16406402
[TBL] [Abstract][Full Text] [Related]
16. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles.
Adams M; Kwon GS
J Pharm Pharm Sci; 2004 Nov; 7(4):1-6. PubMed ID: 15850542
[TBL] [Abstract][Full Text] [Related]
17. Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B.
Falamarzian A; Lavasanifar A
Macromol Biosci; 2010 Jun; 10(6):648-56. PubMed ID: 20352627
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the self assembly of methoxy poly(ethylene oxide)-block-poly(α-benzyl carboxylate-ε-caprolactone) for the solubilization and in vivo delivery of valspodar.
Binkhathlan Z; Elhasi S; Brocks DR; Lavasanifar A
Curr Drug Deliv; 2012 Mar; 9(2):164-71. PubMed ID: 22283648
[TBL] [Abstract][Full Text] [Related]
19. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
[TBL] [Abstract][Full Text] [Related]
20. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
